Oncotool for Cancer Medications

NCT03952312 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

83

Enrollment

OTHER

Sponsor class

Conditions

Cancer
Cancer, Treatment-Related
Medication Adherence
Communication
Tyrosine Kinase Inhibitor

Interventions

BEHAVIORAL: Oncotool Intervention (symptom reporting + TKI education)
BEHAVIORAL: Oncotool Control (health information)

Sponsor

Northwestern University